IV Market

The supply and demand graph is continually rising with the medical development in diagnoses and treatment. With an estimation, the market is growing with a CAGR (Compound Annual Growth Rate) of 6%. The rising incidence of pandemics and chronic diseases, including COVID-19, dengue, and cancer, along with the growing elderly population, is projected to be a significant driving force for the pharmaceutical industry in the coming years. This is because the demand for IV fluids and treatments will continue to increase to cater to the healthcare needs of these individuals. Moreover, continuous drug delivery device advancements are anticipated to boost the market’s growth substantially. These technological innovations offer more efficient and precise medication administration methods, enhancing patient outcomes and overall healthcare delivery. The technical analysis has witnessed how these advancements are
shaping the future of the IV infusion industry.